about
New advances in targeted gastric cancer treatmentTasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine modelsIpilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use.Emerging options for the treatment of melanoma - focus on ipilimumab.Real-life experience of managing vulval erosive lichen planus: a case-based review and U.K. multicentre case note audit.HPK1 as a novel target for cancer immunotherapy.Genetic cancer vaccines: current status and perspectives.Sylatron: a pegylated interferon for use in melanoma.Insights into melanoma: targeting the mTOR pathway for therapeutics.Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity.Recent progress in peptide vaccination in cancer with a focus on non-small-cell lung cancer.KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.BAMM: a preliminary bibliometric analysis on melanoma manuscripts.Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational study.Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab.Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancerMelanoma patients receive more follow-up care than current guideline recommendations: a study of 546 patients from the general Dutch population
P2860
Q26738548-5F4D6D65-538D-4E18-A829-1DB49E32E96DQ35071167-7C48FDE0-D124-4886-BB89-5D5CCC3A8F4CQ36292634-8A0E493F-5FCE-4388-9372-11BF81E67145Q37031656-8B6FE253-402B-4550-9E88-2E4B19F73670Q37989990-DE33B726-1ED5-46C4-97E1-58A6FF989E38Q38000158-6E3E8B13-22C0-41B7-B18B-C439DE3C4A38Q38009352-F043B420-8411-4AC7-B315-898C93023746Q38012440-7228A5D9-69ED-4A90-8AC1-945347BA4C18Q38012466-D2749882-BDE3-470E-9429-56CB077FC5D4Q38122205-32A4CC62-5CB2-4DB8-94FC-9585AF3AB587Q38168904-15B19539-84FB-4F03-919F-3A1BD42CB491Q41335241-9FB945BE-876E-42FC-83EF-A921B7729984Q45722540-CFAD5099-A44F-40FA-9092-5164B89D7F07Q47752171-A850891D-A78A-4638-A2F9-E825A2346663Q53019791-095E05A3-B2E0-47FC-9F63-A36204B9849DQ57167306-FCF8211E-4F49-41B5-B16E-2E48BB434801Q57414889-1113055D-CA6C-4237-BC38-333B6EBD4CC3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ipilimumab: a novel treatment for metastatic melanoma.
@en
Ipilimumab: a novel treatment for metastatic melanoma.
@nl
type
label
Ipilimumab: a novel treatment for metastatic melanoma.
@en
Ipilimumab: a novel treatment for metastatic melanoma.
@nl
prefLabel
Ipilimumab: a novel treatment for metastatic melanoma.
@en
Ipilimumab: a novel treatment for metastatic melanoma.
@nl
P2093
P2860
P356
P1476
Ipilimumab: a novel treatment for metastatic melanoma.
@en
P2093
Denise K Lowe
Erin E Mancl
Mandy L Gatesman
Morgan E Culver
P2860
P304
P356
10.1345/APH.1P651
P407
P577
2011-04-19T00:00:00Z